The Enterprise Value as of September 2024 (TTM) for PepGen Inc. (PEPG) is 249.89M

According to PepGen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 249.89M. This represents a change of 5.36% compared to the average of 237.19M of the last 4 quarters.

PepGen Inc. (PEPG) Historical Enterprise Value (quarterly & annually)

How has PEPG Enterprise Value performed in the past?

The mean historical Enterprise Value of PepGen Inc. over the last ten years is 196.15M. The current 249.89M Enterprise Value has changed 12.64% with respect to the historical average. Over the past ten years (40 quarters), PEPG's Enterprise Value was at its highest in in the June 2024 quarter at 534.85M. The Enterprise Value was at its lowest in in the June 2022 quarter at -78898781.85.

PepGen Inc. (PEPG) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of PepGen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PepGen Inc. (PEPG) Average Enterprise Value

How has PEPG Enterprise Value performed in the past?

The current Enterprise Value of PepGen Inc. (PEPG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

PepGen Inc. (PEPG) Enterprise Value vs. Peers

How is PEPG’s Enterprise Value compared to its peers?

PepGen Inc.’s Enterprise Value is greater than PMV Pharmaceuticals, Inc. (41.69M), less than Eliem Therapeutics, Inc. (326.52M), greater than MediciNova, Inc. (45.91M), less than Pharvaris N.V. (677.17M), greater than Molecular Partners AG (-9817557.37), less than Mineralys Therapeutics, Inc. (507.98M), greater than AN2 Therapeutics, Inc. (4.27M), greater than Century Therapeutics, Inc. (151.31M), less than Edgewise Therapeutics, Inc. (1.56B), less than C4 Therapeutics, Inc. (429.01M), less than Cullinan Oncology, Inc. (868.10M), less than Tyra Biosciences, Inc. (966.91M), greater than Compass Therapeutics, Inc. (210.26M), greater than Vigil Neuroscience, Inc. (119.22M), less than PureTech Health plc (253.02M), less than Entrada Therapeutics, Inc. (427.88M), greater than Rallybio Corporation (30.91M),

Build a custom stock screener for PepGen Inc. (PEPG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PepGen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PepGen Inc. (PEPG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PepGen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.